Endothelial pro-atherosclerotic response to extracellular diabetic-like environment: Possible role of thioredoxin-interacting protein

Nephrology Dialysis Transplantation

Volumn 25, Issue 7, 2010, Pages 2141-2149

  Zitman Gal, Tali ^a   Green, Janice ^a   Pasmanik Chor, Metsada ^b   Oron Karni, Varda ^b   Bernheim, Jacques ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

advanced glycation end products; diabetes; endothelial cells; thioredoxin interacting protein

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; THIOREDOXIN; THIOREDOXIN INTERACTING PROTEIN; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CARRIER PROTEIN; IMMUNOGLOBULIN RECEPTOR; TXNIP PROTEIN, HUMAN;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; DIABETES MELLITUS; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENETICS; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; CARRIER PROTEINS; CELLS, CULTURED; DIABETES COMPLICATIONS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, IMMUNOLOGIC; THIOREDOXINS; UMBILICAL VEINS;

EID: 77954334710     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp768     Document Type: Article

References (33)

1. Bakker W, Eringa EC, Sipkema P et al. Endothelial dysfunction and diabetes: role of hyperglycaemia, impaired insulin signaling and obesity. Cell Tissue Res 2009; 335: 165-189
2. UK Prospective Diabetes study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998. 352. 837-853.
3. Ahmed N. Advanced glycation endproducts\role in pathology of diabetic complications. Diabetes Res Clin Pract 2005; 67: 3-21
4. Singh R, Barden A, Mori T et al. Advanced glycation end products: a review. Diabetologia 2001; 44: 129-146
5. Stehouwer CD, Lambert J, Donker AJ et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34: 55-68
6. Stern DM, Yan SD, Yan SF et al. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Aging Res Rev 2002; 1: 1-15
7. Kinoshita K, Tanjoh K, Noda A et al. Interleukin-8 production from human umbilical vein endothelial cells during brief hyperglycaemia: the effect of tumor necrotic factor-alpha. J Surg Res 2008; 144: 127-131
8. Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol 2008; 103: 398-406
9. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62: 3-6
10. Rashid G, Benchetrit S, Fishman D et al. Effect of advanced glyca-tion end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int 2004; 66: 1099-1106
11. Talmor Y, Golan E, Benchetrit S et al. Calcitriol blunts the deleterious impact of advanced glycation end products (AGEs) on endothe-lial cells. Am J Physiol Renal Physiol 2008; 294: F1059-F1064
12. Talmor Y, Bernheim J, Klein O et al. Calcitriol blunts pro-atherosclerotic parameters through NFκB and p38. Eur J Clin Invest 2008; 38: 548-554
13. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29
14. Gene Ontology Consortium. Creating the gene ontology resource: design and implementation. Genome Res 2001; 11: 1425-1433
15. Schadt EE, Monks SA, Drake TA et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422: 297-302
16. Thomas PD, Kejariwal A, Campbell MJ et al. PANTHER: a browsa-ble database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acid Res 2003; 31: 334-341
17. Irizarry RA, Hobbs B, Collin F et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264
18. Oliveros J.C. Venny. An interactive tool for comparing lists with Venn diagrams 2007http://bioinfogp.cnb.csic.es/tools/venny/index.html
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25: 402-408
20. Morohoshi M, Fujisawa K, Uchimura I et al. The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann N Y Acad Sci 1995; 748: 562-570
21. Igarashi M, Wakasaki H, Takahara N et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 1999; 103: 185-195
22. Wilmer WA, Dixon CL, Hebert C. Chronic exposure of human mesangial cells to high glucose environment activates the p38 MAPK pathway. Kidney Int 2001; 60: 858-871
23. Perrone L, Devi TS, Hosoya K et al. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 2009; 221: 262-272
24. Ho FM, Liu SH, Liau CS et al. High glucose-induced apoptosis in human endothelial cells ismediatedbysequential activationsofc-Jun NH (2)-terminal kinase and caspase-3. Circulation 2000; 101: 2618-2624
25. Ho FM, Lin WW, Chen BC et al. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal 2006; 18: 391-399
26. Yamawaki H. Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. Curr Opin Nephrol Hypertens 2005; 14: 149-153
27. Chen J, Cha-Molstad H, Szabo A et al. Diabetes induces and calcium channel blockers prevent cardiac expression of pro-apoptotic thiore-doxin-interacting protein. Am J Physiol Endocrinol Metab 2009; 296: 1133-1139
28. Altschmied J, Haendeler J. Thioredoxin-1 and endothelial cell aging: role in cardiovascular diseases. Antioxid Redox Signal 2009; 11: 1733-1740
29. Minn AH, Hafele C, Shalev A. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology 2005; 146: 2397-2405
30. Hirota T, Okano T, Kokame K et al. Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J Biol Chem 2002; 277: 44244-44251
31. Shalev A, Pise-Masison CA, Radonovich M et al. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway. Endocrinology 2002; 143: 3695-3698
32. Kobayashi T, Uehara S, Ikeda T et al. Vitamin D3 up-regulated pro-tein-1 regulates collagen expression in mesangial cells. Kidney Int 2003; 64: 1632-1642
33. Shaked M, Ketzinel-Gilad M, Ariav Y et al. Insulin counteracts glu-cotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets. Diabetologia 2009; 52: 636-644